Tryp Therapeuatics (TRYPF) Coverage Report

Tryp Therapeutics, Inc. Michael Higgins Balance Sheet ($000) Senior Research Analyst Ladenburg Thalmann mhiggins@ladenburg.com Fiscal: F2020 F1Q'21 F2Q'21 F3Q'21 F4Q'21 F2021 F1Q'22 F2Q'22 F3Q'22 F4Q'22 F2022 F2023 F2024 F2025 F2026 F2027 Calendar: 8/31/20 11/30/20 2/28/21 5/31/21 8/31/21 8/31/21 11/30/21 2/28/22 5/31/22 8/31/22 8/31/22 8/31/23 8/31/24 8/31/25 8/31/26 8/31/27 Assets Current assets Cash and cash equivalents $1,019 $682 $6,746 $5,602 $4,138 $4,138 $2,149 $19,261 $14,762 $7,274 $7,274 $38,600 $17,880 $34,844 $40,657 $45,341 Prepaid and advances $29 $143 $487 $457 $462 $462 $467 $471 $476 $481 $481 $486 $490 $495 $500 $505 Other receivables $0 $11 $323 $10 $11 $11 $11 $11 $11 $11 $11 $11 $11 $11 $11 $12 Total current assets $1,048 $836 $7,557 $6,070 $4,611 $4,611 $2,626 $19,743 $15,249 $7,766 $7,766 $39,097 $18,381 $35,351 $41,169 $45,858 Deferred financing $27 $199 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 Intangible assets $961 $973 $17 $17 $17 $17 $18 $18 $18 $18 $18 $18 $19 $19 $19 $19 Total assets $2,035 $2,008 $7,574 $6,087 $4,628 $4,628 $2,644 $19,761 $15,267 $7,784 $7,784 $39,115 $18,400 $35,370 $41,187 $45,877 Liabilities and shareholder's equity Current liabilities Trade and other payables $188 $392 $106 $119 $120 $120 $121 $122 $123 $125 $125 $126 $127 $128 $130 $131 Loans from shareholder $5 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 $0 Total current liabilities $193 $392 $106 $119 $120 $120 $121 $122 $123 $125 $125 $126 $127 $128 $130 $131 Shareholder's equity Share capital $2,265 $2,400 $9,834 $9,996 $10,096 $10,096 $10,197 $10,299 $10,402 $10,506 $10,506 $10,611 $10,717 $10,824 $10,933 $11,042 Contributed surplus $0 $162 $969 $1,879 $378 $378 ($1,649) $15,425 $10,888 $3,362 $3,362 $34,648 $13,889 $30,813 $36,586 $41,229 Accumulated deficit ($423) ($946) ($3,336) ($5,907) ($5,966) ($5,966) ($6,026) ($6,086) ($6,147) ($6,208) ($6,208) ($6,271) ($6,333) ($6,397) ($6,461) ($6,525) Total shareholder's equity $1,842 $1,616 $7,468 $5,968 $4,508 $4,508 $2,523 $19,638 $15,143 $7,659 $7,659 $38,989 $18,273 $35,241 $41,058 $45,746 Total liabilities and shareholder's equity $2,035 $2,008 $7,574 $6,087 $4,628 $4,628 $2,644 $19,761 $15,267 $7,784 $7,784 $39,115 $18,400 $35,370 $41,187 $45,877 Sources: www.sedar.com and Ladenburg Thalmann; Figures in Canadian dollars Projected Actual Michael Higgins 212.409.2074 Tryp Therapeutics, Inc. (TRYPF) Page 41